000 | 01288cam a22003135a 4500 | ||
---|---|---|---|
001 | 17921915 | ||
005 | 20160217145113.0 | ||
008 | 131029t2014 caua frb 001 0 eng d | ||
020 | _a9780123820303 (alk. paper) | ||
040 |
_aDLC _beng _cDLC _dDLC _dEG-ScBUE _dEG-ScBUE |
||
082 | 0 | 4 |
_a615.19 _bSIL _222 |
100 | 1 |
_aSilverman, Richard B. _939174 |
|
245 | 1 | 4 |
_aThe organic chemistry of drug design and drug action / _cRichard B. Silverman, Mark W. Holladay. |
250 | _a3rd ed. | ||
260 |
_aSan Diego : _bAcademic Press / Elsevier, _cc.2014. |
||
300 |
_axviii, 517 p. : _bill. ; _c29 cm. |
||
500 | _aIndex : p. 507-517. | ||
500 | _aIncludes appendix. | ||
504 | _aIncludes bibliographic references. | ||
505 | 0 | _aIntroduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems. | |
650 | 7 |
_aPharmaceutical chemistry. _2BUEsh _930027 |
|
650 | 0 |
_aBioorganic chemistry. _2BUEsh |
|
650 | 0 |
_aMolecular pharmacology. _2BUEsh |
|
650 | 7 |
_aDrugs _xDesign. _2BUEsh _930136 |
|
651 | _2BUEsh | ||
653 |
_bPPhrm _cJuly2015 _cJanuary2016 _cFebruary2016 |
||
700 | 1 | _aHolladay, Mark W. | |
942 | _2ddc | ||
999 |
_c20096 _d20068 |